SOF/VEL for 12 Weeks Results in High SVR12 Rates in Subjects with Negative Predictors of Response to Treatment: An Integrated Analysis of Efficacy from the Astral-1, Astral-2 and Astral-3 Studies

Category Primary study
JournalJournal of Hepatology
Year 2016
This article has no abstract
Epistemonikos ID: 246f47fea9db04a73e28dbe3ad6df7c1611dd212
First added on: Aug 01, 2019